|
|
Top Feature |
|
Can FDA Control Drug Prices? |
FDA approval of generics following the loss of patent protection can send brand prices plummeting. Market approval of additional brands can have a similar effect. But does FDA do enough to facilitate market approval of alternative products? Or do its actions delay market entry of potential competitors. Jill Wechsler reports ... /Read more/ |
|
|
Advertisement |
The ZS Explorer Study finds that pharma investments in sales force effectiveness boost revenue 1 - 7%. That might not sound like much, but given their size and scale, pharmacos can achieve a substantial return on sales force effectiveness investments. Read the report to see the latest data on pharma sales force effectiveness. |
|
Canada |
|
|
Advertisement |
SPEED TO INSIGHT: 4 Strategies you need to maximize the value of your data assets On Demand Join Hewlett Packard Enterprise and Linguamatics as they discuss the right questions to ask about your company's analytics capabilities to gain a competitive advantage. Learn more
|
|
Europe |
|
Orphans in the Storm
|
As a European politician attacks abuses of the orphan drug scheme, a new EU report extols its virtues. Reflector asks: in Europe, does the right hand know what the left hand is doing? ... /Read more/ |
|
|
Global |
|
EU–US Data Privacy Concerns Intensify
|
Reactive, hastily enforced regulations can easily jeopardize the sound conduct of a clinical trial and its data flow, potentially threatening both subject safety and data quality. Susan Shelby reports
... /Read more/ |
|
|
|
Industry update |
//John Temperato joined Melinta Therapeutics (New Haven, CT) as President and Chief Operating Officer.//GA Communication Group (Chicago, IL) announced its rebirth as Sandbox. Sandbox’s 350 employees will be based in seven offices throughout the US and Canada.//MRIGlobal (Kansas City, MO) announced that Steve Phillips joined the as Vice President of Sales and Marketing.//Kantar Health (New York, NY) announced that Stephen Potts has been named Managing Director of Kantar Health UK. The company also promoted Michel Murino to the newly created role of chief executive officer for Kantar Health Europe.// |
|
|
|
|